gl1 tirzepatide (GLP-1 / GIP) Pharmacogenomics of Tirzepatide: Genomic Insights
Description
Initiation rates for ADM GLP-1 RA increased slightly in March 2024, relative to December 2023 (+1.72%)
Tirzepatide can affect the absorption of oral medications due to delayed gastric emptying
2 With the investigation and availability of semaglutide 2 mg, data on comparative efficacy between tirzepatide and this higher dose of semaglutide may be relevant to make clinical decisions
Intensified GI side effects Alcohol irritates the stomach lining and alters gut motility independently of tirzepatide
